id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-D-0244-0006,FDA,FDA-2003-D-0244,Guidance,Supporting & Related Material,GDL-Guidance,2005-06-21T04:00:00Z,2005,6,,,2008-04-12T00:55:07Z,,0,0,090000648048ed39
FDA-2003-D-0244-0004,FDA,FDA-2003-D-0244,Guidance,Supporting & Related Material,GDL-Guidance,2005-06-21T04:00:00Z,2005,6,,,2008-04-12T00:55:07Z,,0,0,090000648048ed19
FDA-2003-D-0244-0007,FDA,FDA-2003-D-0244,FDA,Notice,NAD-Notice of Availability of Data,2005-06-21T04:00:00Z,2005,6,2005-06-20T04:00:00Z,2006-06-21T03:59:59Z,2008-04-12T00:55:07Z,,0,0,090000648048ed3e
FDA-2003-D-0244-0005,FDA,FDA-2003-D-0244,Guidance,Supporting & Related Material,GDL-Guidance,2005-06-21T04:00:00Z,2005,6,,,2008-04-12T00:55:07Z,,0,0,090000648048ed36